Sirio Pharma Co Ltd
SZSE:300791

Watchlist Manager
Sirio Pharma Co Ltd Logo
Sirio Pharma Co Ltd
SZSE:300791
Watchlist
Price: 27.35 CNY -2.15% Market Closed
Market Cap: 6.5B CNY
Have any thoughts about
Sirio Pharma Co Ltd?
Write Note

Sirio Pharma Co Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sirio Pharma Co Ltd
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Sirio Pharma Co Ltd
SZSE:300791
Total Receivables
ÂĄ668.7m
CAGR 3-Years
25%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Total Receivables
ÂĄ4.1B
CAGR 3-Years
-3%
CAGR 5-Years
-5%
CAGR 10-Years
4%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Total Receivables
ÂĄ377.3m
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Total Receivables
ÂĄ465.5m
CAGR 3-Years
22%
CAGR 5-Years
26%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Total Receivables
ÂĄ597.4m
CAGR 3-Years
15%
CAGR 5-Years
11%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Total Receivables
ÂĄ126.6m
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sirio Pharma Co Ltd
Glance View

Market Cap
6.5B CNY
Industry
Consumer products

Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
35.1 CNY
Undervaluation 22%
Intrinsic Value
Price

See Also

What is Sirio Pharma Co Ltd's Total Receivables?
Total Receivables
668.7m CNY

Based on the financial report for Dec 31, 2023, Sirio Pharma Co Ltd's Total Receivables amounts to 668.7m CNY.

What is Sirio Pharma Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
22%

Over the last year, the Total Receivables growth was 36%. The average annual Total Receivables growth rates for Sirio Pharma Co Ltd have been 25% over the past three years , 22% over the past five years .

Back to Top